Design of Multi-Binding-Site Inhibitors, Ligand Efficiency, and Consensus Screening of Avian Influenza H5N1 Wild-Type Neuraminidase and of the Oseltamivir-Resistant H274Y Variant

Abstract

The binding sites of wild-type avian influenza A H5N1 neuraminidase, as well as those of the Tamiflu (oseltamivir)-resistant H274Y variant, were explored computationally to design inhibitors that target simultaneously several adjacent binding sites of the open conformation of the virus protein. The compounds with the best computed free energies of binding, in agreement by two docking methods, consensus scoring, and ligand efficiency values, suggest that mimicking a polysaccharide, beta-lactam, and other structures, including known drugs, could be routes for multibinding site inhibitor design. This new virtual screening method based on consensus scoring and ligand efficiency indices is introduced, which allows the combination of pharmacodynamic and pharmacokinetic properties into unique measures.

DOI: 10.1021/ci800242z

Extracted Key Phrases

4 Figures and Tables

Showing 1-10 of 21 references

1) World Health Organization. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO

  • 2008

6) European Union. European Center for Disease Prevention and Control. Resistance to oseltamivir (Tamiflu) found in some European Influenza samples

  • 2008

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

  • A J Hay, S J Gamblin
  • 2008

Am. Chem. Soc

  • 2007

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design

  • S J Gamblin, J J Skehel
  • 2006
Showing 1-9 of 9 extracted citations

Statistics

010020020102011201220132014201520162017
Citations per Year

126 Citations

Semantic Scholar estimates that this publication has received between 17 and 453 citations based on the available data.

See our FAQ for additional information.